173 related articles for article (PubMed ID: 31300540)
21. STAT5A/B Blockade Sensitizes Prostate Cancer to Radiation through Inhibition of RAD51 and DNA Repair.
Maranto C; Udhane V; Hoang DT; Gu L; Alexeev V; Malas K; Cardenas K; Brody JR; Rodeck U; Bergom C; Iczkowski KA; Jacobsohn K; See W; Schmitt SM; Nevalainen MT
Clin Cancer Res; 2018 Apr; 24(8):1917-1931. PubMed ID: 29483142
[No Abstract] [Full Text] [Related]
22. ATR-p53 restricts homologous recombination in response to replicative stress but does not limit DNA interstrand crosslink repair in lung cancer cells.
Sirbu BM; Lachmayer SJ; Wülfing V; Marten LM; Clarkson KE; Lee LW; Gheorghiu L; Zou L; Powell SN; Dahm-Daphi J; Willers H
PLoS One; 2011; 6(8):e23053. PubMed ID: 21857991
[TBL] [Abstract][Full Text] [Related]
23. Compromised CDK1 activity sensitizes BRCA-proficient cancers to PARP inhibition.
Johnson N; Li YC; Walton ZE; Cheng KA; Li D; Rodig SJ; Moreau LA; Unitt C; Bronson RT; Thomas HD; Newell DR; D'Andrea AD; Curtin NJ; Wong KK; Shapiro GI
Nat Med; 2011 Jun; 17(7):875-82. PubMed ID: 21706030
[TBL] [Abstract][Full Text] [Related]
24. Prevention of DNA Replication Stress by CHK1 Leads to Chemoresistance Despite a DNA Repair Defect in Homologous Recombination in Breast Cancer.
Meyer F; Becker S; Classen S; Parplys AC; Mansour WY; Riepen B; Timm S; Ruebe C; Jasin M; Wikman H; Petersen C; Rothkamm K; Borgmann K
Cells; 2020 Jan; 9(1):. PubMed ID: 31963582
[TBL] [Abstract][Full Text] [Related]
25. Deletion of a small consensus region at 6q15, including the MAP3K7 gene, is significantly associated with high-grade prostate cancers.
Liu W; Chang BL; Cramer S; Koty PP; Li T; Sun J; Turner AR; Von Kap-Herr C; Bobby P; Rao J; Zheng SL; Isaacs WB; Xu J
Clin Cancer Res; 2007 Sep; 13(17):5028-33. PubMed ID: 17785553
[TBL] [Abstract][Full Text] [Related]
26. S100A11 plays a role in homologous recombination and genome maintenance by influencing the persistence of RAD51 in DNA repair foci.
Foertsch F; Szambowska A; Weise A; Zielinski A; Schlott B; Kraft F; Mrasek K; Borgmann K; Pospiech H; Grosse F; Melle C
Cell Cycle; 2016 Oct; 15(20):2766-79. PubMed ID: 27590262
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic exploitation of tumor cell defects in homologous recombination.
Powell SN; Kachnic LA
Anticancer Agents Med Chem; 2008 May; 8(4):448-60. PubMed ID: 18473729
[TBL] [Abstract][Full Text] [Related]
28. CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer.
Johnson SF; Cruz C; Greifenberg AK; Dust S; Stover DG; Chi D; Primack B; Cao S; Bernhardy AJ; Coulson R; Lazaro JB; Kochupurakkal B; Sun H; Unitt C; Moreau LA; Sarosiek KA; Scaltriti M; Juric D; Baselga J; Richardson AL; Rodig SJ; D'Andrea AD; Balmaña J; Johnson N; Geyer M; Serra V; Lim E; Shapiro GI
Cell Rep; 2016 Nov; 17(9):2367-2381. PubMed ID: 27880910
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of homologous recombination with vorinostat synergistically enhances ganciclovir cytotoxicity.
Ladd B; Ackroyd JJ; Hicks JK; Canman CE; Flanagan SA; Shewach DS
DNA Repair (Amst); 2013 Dec; 12(12):1114-21. PubMed ID: 24231389
[TBL] [Abstract][Full Text] [Related]
30. FEN1 endonuclease as a therapeutic target for human cancers with defects in homologous recombination.
Guo E; Ishii Y; Mueller J; Srivatsan A; Gahman T; Putnam CD; Wang JYJ; Kolodner RD
Proc Natl Acad Sci U S A; 2020 Aug; 117(32):19415-19424. PubMed ID: 32719125
[TBL] [Abstract][Full Text] [Related]
31. Methotrexate-mediated inhibition of RAD51 expression and homologous recombination in cancer cells.
Du LQ; Du XQ; Bai JQ; Wang Y; Yang QS; Wang XC; Zhao P; Wang H; Liu Q; Fan FY
J Cancer Res Clin Oncol; 2012 May; 138(5):811-8. PubMed ID: 22274865
[TBL] [Abstract][Full Text] [Related]
32. Rad51 and BRCA2--New molecular targets for sensitizing glioma cells to alkylating anticancer drugs.
Quiros S; Roos WP; Kaina B
PLoS One; 2011; 6(11):e27183. PubMed ID: 22073281
[TBL] [Abstract][Full Text] [Related]
33. Hypoxia down-regulates DNA double strand break repair gene expression in prostate cancer cells.
Meng AX; Jalali F; Cuddihy A; Chan N; Bindra RS; Glazer PM; Bristow RG
Radiother Oncol; 2005 Aug; 76(2):168-76. PubMed ID: 16026872
[TBL] [Abstract][Full Text] [Related]
34. Defective DNA strand break repair after DNA damage in prostate cancer cells: implications for genetic instability and prostate cancer progression.
Fan R; Kumaravel TS; Jalali F; Marrano P; Squire JA; Bristow RG
Cancer Res; 2004 Dec; 64(23):8526-33. PubMed ID: 15574758
[TBL] [Abstract][Full Text] [Related]
35. RING finger nuclear factor RNF168 is important for defects in homologous recombination caused by loss of the breast cancer susceptibility factor BRCA1.
Muñoz MC; Laulier C; Gunn A; Cheng A; Robbiani DF; Nussenzweig A; Stark JM
J Biol Chem; 2012 Nov; 287(48):40618-28. PubMed ID: 23055523
[TBL] [Abstract][Full Text] [Related]
36. RAD51-Mediated DNA Homologous Recombination Is Independent of
Sinha A; Saleh A; Endersby R; Yuan SH; Chokshi CR; Brown KR; Kuzio B; Kauppinen T; Singh SK; Baker SJ; McKinnon PJ; Katyal S
Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33138032
[TBL] [Abstract][Full Text] [Related]
37. Polo-like kinase 1 mediates BRCA1 phosphorylation and recruitment at DNA double-strand breaks.
Chabalier-Taste C; Brichese L; Racca C; Canitrot Y; Calsou P; Larminat F
Oncotarget; 2016 Jan; 7(3):2269-83. PubMed ID: 26745677
[TBL] [Abstract][Full Text] [Related]
38. The CDK1 inhibitor RO3306 improves the response of BRCA-proficient breast cancer cells to PARP inhibition.
Xia Q; Cai Y; Peng R; Wu G; Shi Y; Jiang W
Int J Oncol; 2014 Mar; 44(3):735-44. PubMed ID: 24378347
[TBL] [Abstract][Full Text] [Related]
39. Loss of PTEN-assisted G2/M checkpoint impedes homologous recombination repair and enhances radio-curability and PARP inhibitor treatment response in prostate cancer.
Mansour WY; Tennstedt P; Volquardsen J; Oing C; Kluth M; Hube-Magg C; Borgmann K; Simon R; Petersen C; Dikomey E; Rothkamm K
Sci Rep; 2018 Mar; 8(1):3947. PubMed ID: 29500400
[TBL] [Abstract][Full Text] [Related]
40. Riccardin D Exerts Its Antitumor Activity by Inducing DNA Damage in PC-3 Prostate Cancer Cells In Vitro and In Vivo.
Hu Z; Kong F; Si M; Tian K; Yu LX; Young CY; Yuan H; Lou H
PLoS One; 2013; 8(9):e74387. PubMed ID: 24069304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
